What each role should evaluate — and ask first
A clinic owner evaluating White Label Rx should first ask whether the goal is to improve their current prescription ordering workflow or to launch a parallel DTC brand. If the answer is the former — lower per-vial cost, better refill day workflow, multi-pharmacy routing — White Label Rx is the wrong platform, and a clinic ordering layer with pass-through pricing is the right evaluation. If the answer is the latter — building a separate branded online healthcare business — then the $499/mo platform and $7,500 White Glove setup is the budget question to evaluate against expected DTC revenue.
An operations lead should ask whether their daily problem is consumer brand management or prescription batch ops. White Label Rx solves patient subscriptions, storefront conversions, and affiliate marketing. It does not solve rejected orders in a batch, clinic cart validation before checkout, or multi-pharmacy routing for a single refill day. For those needs, the evaluation should focus on what the ordering platform does before money moves — which is where Fizy Health and White Label Rx diverge completely.